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Protective effect of 
vitamin D in diabetic 
nephropathy
New studies have provided surprising 
results regarding the eﬀects of vitamin D 
in situations other than calcium and phos-
phate homeostasis. As they report in this 
issue, Zhang et al. studied mice deﬁcient 
in the vitamin D nuclear receptor and 
induced diabetes by injection of strep-
tozotocin. They found that diabetic mice 
lacking the vitamin D receptor had more 
severe albuminuria and glomerulosclero-
sis than their wild-type controls. Further, 
these animals expressed more transform-
ing growth factor-β (TGF-β) and devel-
oped more sclerosis by deposition of a 
number of extracellular matrix proteins 
such as ﬁbronectin. Recent studies pub-
lished in Kidney International showed 
that vitamin D receptor is a transcrip-
tional regulator of renin; in the present 
paper, the authors found that renin, angio-
tensinogen, and connective tissue growth 
factor increased in the kidneys of receptor 
knockout mice. These in vivo studies were 
supplemented by in vitro studies showing 
that 1,25-dihydroxyvitmain D3 inhibited 
high glucose, induced ﬁbronectin pro-
duction in cultured mesangial cells, and 
increased nephrin expression in cultured 
podocytes, as well as suppressing the acti-
vation of the renin–angiotensin system 
and TGF-β in mesangial and juxtaglomer-
ular cells. These ﬁndings demonstrate that 
vitamin D and its receptor play a salutary 
role in the pathogenesis of ﬁbrosis in dia-
betic nephropathy. See page 163.
Biocompatible 
peritoneal dialysis 
solutions
Kidney International is often accused of 
failing to publish negative studies; we now 
have an interesting one. Peritoneal dialy-
sis ﬂuids are ‘unnatural’ in that they have 
compositions quite diﬀerent from that of 
body ﬂuids in general. Their high glucose 
levels and other components are thought 
to lead to inflammation and eventual 
ﬁbrosis of the peritoneal membranes. The 
development of ‘biocompatible’ solutions 
was thus hailed as a deﬁnitive advance in 
this ﬁeld; a number of studies have shown 
that these solutions are better in that they 
reduce inflammation and protect the 
peritoneal membranes from the dreaded 
peritoneal failure due to ﬁbrosis. Yet no 
randomized controlled studies had been 
published comparing the use of biocom-
patible with standard solutions. A new 
study by Fan et al. now compares the two 
types of solutions. After a 1-year follow-up 
in a group of patients with similar clinical 
states, the authors found no signiﬁcant 
diﬀerence in urea, creatinine clearance, 
or secondary end points between the two 
groups. This ﬁnding is disappointing, but 
it shows that logic can be wrong in sci-
entiﬁc studies. However, the search for 
better dialysis solutions must continue, 
since the cause of peritoneal ﬁbrosis and 
inﬂammation is clearly the solution itself. 
See page 200.
Fructose and kidney 
stones
Countless papers on fructose and kidney 
disease have been done, many of them 
recently published. In this issue, Taylor 
and Curhan describe the relationship 
between fructose intake and incident 
kidney stones in the Nurses’ Health Study 
I (93 730 older women), the Nurses’ 
Health Study II, and the Health Profes-
sionals Follow-up Study (45,984 men). 
They estimated fructose intake every 
4 years on the basis of food frequency 
questionnaires. Cox proportional hazard 
regressions were adjusted for age, body 
mass index, thiazide use, caloric intake, 
and other dietary factors. During a com-
bined 48 years of follow-up, almost 5,000 
stone episodes were identiﬁed. Patients 
with the highest fructose intake had a 
higher incidence of kidney stones than 
those with the lowest fructose intake. 
This eﬀect seemed to be speciﬁc for fruc-
tose, as the intake of other carbohydrates 
was not associated with risk of kidney 
stones. These surprising results raise the 
question of the potential mechanism 
by which this sugar leads to increased 
risk of kidney stones. Investigation of 
the mechanism is an urgent issue given 
that the intake of fructose is increas-
ing, at least in industrialized countries. 
See page 207.
